66 related articles for article (PubMed ID: 9876562)
1. Effect of the formulation parameters on the characteristics of pellets.
Fekete R; Zelkó R; Marton S; Rácz I
Drug Dev Ind Pharm; 1998 Nov; 24(11):1073-6. PubMed ID: 9876562
[TBL] [Abstract][Full Text] [Related]
2. Oral controlled release optimization of pellets prepared by extrusion-spheronization processing.
Bianchini R; Vecchio C
Farmaco; 1989 Jun; 44(6):645-54. PubMed ID: 2803450
[TBL] [Abstract][Full Text] [Related]
3. Multivariate optimization of formulation and process variables influencing physico-mechanical characteristics of site-specific release isoniazid pellets.
Pund S; Joshi A; Vasu K; Nivsarkar M; Shishoo C
Int J Pharm; 2010 Mar; 388(1-2):64-72. PubMed ID: 20035851
[TBL] [Abstract][Full Text] [Related]
4. Development and optimization of solid dispersion containing pellets of itraconazole prepared by high shear pelletization.
Ye G; Wang S; Heng PW; Chen L; Wang C
Int J Pharm; 2007 Jun; 337(1-2):80-7. PubMed ID: 17241757
[TBL] [Abstract][Full Text] [Related]
5. Dissolution test for site-specific release isoniazid pellets in USP apparatus 3 (reciprocating cylinder): optimization using response surface methodology.
Joshi A; Pund S; Nivsarkar M; Vasu K; Shishoo C
Eur J Pharm Biopharm; 2008 Jun; 69(2):769-75. PubMed ID: 18191554
[TBL] [Abstract][Full Text] [Related]
6. Optimization of propranolol hydrochloride sustained-release pellets using box-behnken design and desirability function.
Bodea A; Leucuta SE
Drug Dev Ind Pharm; 1998 Feb; 24(2):145-55. PubMed ID: 15605444
[TBL] [Abstract][Full Text] [Related]
7. Bi-layered self-emulsifying pellets prepared by co-extrusion and spheronization: influence of formulation variables and preliminary study on the in vivo absorption.
Iosio T; Voinovich D; Grassi M; Pinto JF; Perissutti B; Zacchigna M; Quintavalle U; Serdoz F
Eur J Pharm Biopharm; 2008 Jun; 69(2):686-97. PubMed ID: 18191390
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of surfactant and hydrophobizing agent concentration in relation to the optimal particle size of metered-dose inhalers.
Fedina LT; Zelkó R; Fedina LI; Szabados Z; Szántó M
Drug Dev Ind Pharm; 1998 Sep; 24(9):853-6. PubMed ID: 9876536
[TBL] [Abstract][Full Text] [Related]
9. [Controlled release of pseudoephedrine HCl from pellets].
Vertommen J
Verh K Acad Geneeskd Belg; 1997; 59(6):451-88. PubMed ID: 9543819
[TBL] [Abstract][Full Text] [Related]
10. Drug release from a multiparticulate pellet system.
Zimm KR; Schwartz JB; O'Connor RE
Pharm Dev Technol; 1996 Apr; 1(1):37-42. PubMed ID: 9552329
[TBL] [Abstract][Full Text] [Related]
11. Preparation of floating pellets with verapamil hydrochloride.
Sawicki W; Głód J
Acta Pol Pharm; 2004; 61(3):185-90. PubMed ID: 15481243
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical approaches to preparing pelletized dosage forms using the extrusion-spheronization process.
Trivedi NR; Rajan MG; Johnson JR; Shukla AJ
Crit Rev Ther Drug Carrier Syst; 2007; 24(1):1-40. PubMed ID: 17430098
[TBL] [Abstract][Full Text] [Related]
13. [Application of computer image analysis for characterization of pellets].
Balogh E; Kállai N; Dredán J; Lengyel M; Klebovich I; Antal I
Acta Pharm Hung; 2007; 77(2):123-31. PubMed ID: 17933272
[TBL] [Abstract][Full Text] [Related]
14. Investigation on drug dissolution and particle characteristics of pellets related to manufacturing process variables of high-shear granulation.
Dévay A; Mayer K; Pál S; Antal I
J Biochem Biophys Methods; 2006 Nov; 69(1-2):197-205. PubMed ID: 16650480
[TBL] [Abstract][Full Text] [Related]
15. Properties of drug-containing spherical pellets produced by a hot-melt extrusion and spheronization process.
Young CR; Koleng JJ; McGinity JW
J Microencapsul; 2003; 20(5):613-25. PubMed ID: 12909545
[TBL] [Abstract][Full Text] [Related]
16. Solid self-emulsifying nitrendipine pellets: preparation and in vitro/in vivo evaluation.
Wang Z; Sun J; Wang Y; Liu X; Liu Y; Fu Q; Meng P; He Z
Int J Pharm; 2010 Jan; 383(1-2):1-6. PubMed ID: 19698771
[TBL] [Abstract][Full Text] [Related]
17. Alginate-based pellets prepared by extrusion/spheronization: a preliminary study on the effect of additive in granulating liquid.
Sriamornsak P; Nunthanid J; Luangtana-anan M; Puttipipatkhachorn S
Eur J Pharm Biopharm; 2007 Aug; 67(1):227-35. PubMed ID: 17276664
[TBL] [Abstract][Full Text] [Related]
18. Drug solubility effects on predicting optimum conditions for extrusion and spheronization of pellets.
Hileman GA; Upadrashta SM; Neau SH
Pharm Dev Technol; 1997 Feb; 2(1):43-52. PubMed ID: 9552430
[TBL] [Abstract][Full Text] [Related]
19. Stress relaxation test for the characterization of the viscoelasticity of pellets.
Cespi M; Bonacucina G; Misici-Falzi M; Golzi R; Boltri L; Palmieri GF
Eur J Pharm Biopharm; 2007 Sep; 67(2):476-84. PubMed ID: 17493792
[TBL] [Abstract][Full Text] [Related]
20. Formulation and Optimization of Lansoprazole Pellets Using Factorial Design Prepared by Extrusion-Spheronization Technique Using Carboxymethyl Tamarind Kernel Powder.
Muley SS; Nandgude T; Poddar S
Recent Pat Drug Deliv Formul; 2017; 11(1):54-66. PubMed ID: 28088896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
